FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2989804764> ?p ?o ?g. }

• W2989804764 endingPage "147" @default.
• W2989804764 startingPage "133" @default.
• W2989804764 abstract "Treatment guidelines recommend low-dose corticosteroids as short-term therapy among rheumatoid arthritis (RA) patients. However, it may be difficult to wean/eliminate steroids once initiated. Initiation of more effective therapies such as biologics may help to taper corticosteroid use. The objective was to examine the impact of adalimumab (ADA) initiation on steroid utilization and non-drug medical costs among patients with RA. A retrospective analysis was conducted among adult RA patients initiating ADA as the initial biologic in the MarketScan Database (2012–2016). Study outcomes included whether oral/injectable steroids were used, daily dose, dosage categories (< 5 and ≥ 5 mg/day), number of steroid injections, and non-drug medical costs. Outcomes were compared 6 months pre- and post-ADA initiation. Mixed effects logistic, classical linear, multinomial logistic models, and linear model with a log link and gamma distribution were used to adjust for patient demographic and health characteristics. The sample included 7404 ADA initiators. Compared to pre-ADA initiation, in the post-initiation period there was a reduction in proportions of patients using oral steroids (from 71.80 to 62.56%) and injectable steroids (from 34.91 to 29.88%), average daily dose of oral steroids (from 3.30 to 2.62 mg/day), patients with dose ≥ 5 mg/day (from 21.76 to 16.34%), number of injections (from 0.64 to 0.53), and non-drug medical costs (from $5356.30 to $5146.84) (P < 0.01). The multivariate analysis produced similar patterns. For example, post-ADA initiation, patients were less likely to use oral steroids [odds ratio (OR) 0.51; 95% confidence interval (CI) 0.47–0.56]; coefficient estimate for daily dose reduction was − 0.68 (95% CI − 0.81 to − 0.56); ratio estimate for medical costs was 0.91 (95% CI 0.86–0.97). Among patients with RA, following ADA initiation, there is a reduction in steroid utilization and dosage, and non-drug medical costs. Prospective studies should be conducted to confirm this relationship in the future." @default.
• W2989804764 created "2019-12-05" @default.
• W2989804764 creator A5001777751 @default.
• W2989804764 creator A5006070255 @default.
• W2989804764 creator A5017225305 @default.
• W2989804764 creator A5023973423 @default.
• W2989804764 creator A5035275013 @default.
• W2989804764 creator A5038967816 @default.
• W2989804764 creator A5045103116 @default.
• W2989804764 date "2019-11-18" @default.
• W2989804764 modified "2023-09-27" @default.
• W2989804764 title "Retrospective Analysis of the Impact of Adalimumab Initiation on Corticosteroid Utilization and Medical Costs Among Biologic-Naïve Patients with Rheumatoid Arthritis" @default.
• W2989804764 cites W1964496233 @default.
• W2989804764 cites W1989162705 @default.
• W2989804764 cites W2012748985 @default.
• W2989804764 cites W2020190536 @default.
• W2989804764 cites W2039282281 @default.
• W2989804764 cites W2043850370 @default.
• W2989804764 cites W2057140068 @default.
• W2989804764 cites W2061326496 @default.
• W2989804764 cites W2077534364 @default.
• W2989804764 cites W2085318733 @default.
• W2989804764 cites W2105648357 @default.
• W2989804764 cites W2107243338 @default.
• W2989804764 cites W2110345763 @default.
• W2989804764 cites W2119390151 @default.
• W2989804764 cites W2127608887 @default.
• W2989804764 cites W2129168200 @default.
• W2989804764 cites W2171372903 @default.
• W2989804764 cites W2729905836 @default.
• W2989804764 cites W2735258747 @default.
• W2989804764 cites W2740013065 @default.
• W2989804764 cites W2971217817 @default.
• W2989804764 doi "https://doi.org/10.1007/s40744-019-00184-5" @default.
• W2989804764 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7021911" @default.
• W2989804764 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31741182" @default.
• W2989804764 hasPublicationYear "2019" @default.
• W2989804764 type Work @default.
• W2989804764 sameAs 2989804764 @default.
• W2989804764 citedByCount "0" @default.
• W2989804764 crossrefType "journal-article" @default.
• W2989804764 hasAuthorship W2989804764A5001777751 @default.
• W2989804764 hasAuthorship W2989804764A5006070255 @default.
• W2989804764 hasAuthorship W2989804764A5017225305 @default.
• W2989804764 hasAuthorship W2989804764A5023973423 @default.
• W2989804764 hasAuthorship W2989804764A5035275013 @default.
• W2989804764 hasAuthorship W2989804764A5038967816 @default.
• W2989804764 hasAuthorship W2989804764A5045103116 @default.
• W2989804764 hasBestOaLocation W29898047641 @default.
• W2989804764 hasConcept C126322002 @default.
• W2989804764 hasConcept C151956035 @default.
• W2989804764 hasConcept C167135981 @default.
• W2989804764 hasConcept C2776804153 @default.
• W2989804764 hasConcept C2777575956 @default.
• W2989804764 hasConcept C2780035454 @default.
• W2989804764 hasConcept C2780132546 @default.
• W2989804764 hasConcept C2781059491 @default.
• W2989804764 hasConcept C71924100 @default.
• W2989804764 hasConcept C98274493 @default.
• W2989804764 hasConceptScore W2989804764C126322002 @default.
• W2989804764 hasConceptScore W2989804764C151956035 @default.
• W2989804764 hasConceptScore W2989804764C167135981 @default.
• W2989804764 hasConceptScore W2989804764C2776804153 @default.
• W2989804764 hasConceptScore W2989804764C2777575956 @default.
• W2989804764 hasConceptScore W2989804764C2780035454 @default.
• W2989804764 hasConceptScore W2989804764C2780132546 @default.
• W2989804764 hasConceptScore W2989804764C2781059491 @default.
• W2989804764 hasConceptScore W2989804764C71924100 @default.
• W2989804764 hasConceptScore W2989804764C98274493 @default.
• W2989804764 hasFunder F4320309117 @default.
• W2989804764 hasIssue "1" @default.
• W2989804764 hasLocation W29898047641 @default.
• W2989804764 hasLocation W29898047642 @default.
• W2989804764 hasLocation W29898047643 @default.
• W2989804764 hasOpenAccess W2989804764 @default.
• W2989804764 hasPrimaryLocation W29898047641 @default.
• W2989804764 hasRelatedWork W1963607473 @default.
• W2989804764 hasRelatedWork W2006568643 @default.
• W2989804764 hasRelatedWork W2095714646 @default.
• W2989804764 hasRelatedWork W2168751860 @default.
• W2989804764 hasRelatedWork W2760739255 @default.
• W2989804764 hasRelatedWork W2793666661 @default.
• W2989804764 hasRelatedWork W2945936762 @default.
• W2989804764 hasRelatedWork W3217041469 @default.
• W2989804764 hasRelatedWork W4300786425 @default.
• W2989804764 hasRelatedWork W8149610 @default.
• W2989804764 hasVolume "7" @default.
• W2989804764 isParatext "false" @default.
• W2989804764 isRetracted "false" @default.
• W2989804764 magId "2989804764" @default.
• W2989804764 workType "article" @default.